-- GoodRx Holdings (GDRX) reported Q1 adjusted earnings late Wednesday of $0.07 per diluted share, down from $0.09 a year earlier.
Analysts polled by FactSet expected $0.07.
Revenue in the three months ended March 31 fell to $194 million from $203 million a year earlier.
Analysts surveyed by FactSet expected $185.4 million.
The company expects full-year revenue of $765 million to $785 million.
Analysts polled by FactSet expect $764.8 million.
GoodRx shares rose 2.1% in after-hours trading.